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Background: Endoscopic resection has become standard therapy for selected patients with early gastric carcinoma
(EGC). However, the preoperative diagnostic accuracy for excluding submucosal (SM) invasion is not precise.
Moreover, histologic features predicting SM invasion in gastric carcinomas (SMiGC) have not been studied
extensively.
Methods: Pre-treatment gastric biopsies from 60 patients with SM invasion who underwent endoscopic resection
were reviewed and compared to 58 biopsies of lesions confirmed to be intramucosal carcinomas (IMC). For
validation of the results, an independent cohort consisting of 616 gastric biopsies confirmed as EGC were analyzed.
For statistical analyses, χ-square test, Fisher’s exact test and multiple logistic progression tests were used.
Results: In the biopsy specimens of patients with SMiGCs, differentiated histology, poorly differentiated
component, wisps of muscularis mucosa, tumor cribriforming, papillary architecture, desmoplasia and intraglandular
eosinophilic necrotic debris (IEND) were observed in 96.7%, 36.7%, 16.7%, 16.7%, 23.3%, 40%, and 46.7% of cases,
respectively, while the same features were observed in 100%, 5.2%, 0%, 1.7%, 5.2%, 19%, and 22.4% of biopsies with
IMC. In multivariate analyses, poorly differentiated component [odds ratio (OR), 9.59, p = 0.002], IEND [OR, 6.23,
p = 0.012], tumor cribriforming [OR, 4.66, p = 0.03] and papillary architecture [OR, 5.52, p = 0.018] were significantly
associated with the detection of SM invasion. In the validation cohort, poorly differentiated component (p = 0.003)
and papillary architecture (p = 0.008) remained significant.
Conclusion: Poorly differentiated component and papillary architecture are significant histopathologic predictors of
SM invasion in pretreatment gastric biopsies of lesions considered for endoscopic therapy. Additional prospective
studies are warranted to confirm our findings.
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Over the last decade, the management options for patients
with early gastric cancer (EGC) have increased, largely
due to the advent of therapeutic endoscopy, which has
been associated with a high cure rate with few treatment-
associated morbidities [1]. Endoscopic mucosal resection
(EMR) is now established as the treatment of choice for
differentiated intramucosal adenocarcinomas (IMC) mea-
suring ≤ 20 mm and devoid of ulceration [2]. Furthermore,
the more recently introduced endoscopic submucosal dis-
section (ESD), which allows dissection along the deep sub-
mucosal (SM) layer and facilitates one-piece resection, has
led to expanded indications for endoscopic resection. To
date, ESD can be offered for IMC regardless of mass size
without ulcer, ulcerated IMC < 30 mm in size, or minute
SM invasive cancer < 30 mm in size [3]. However, in con-
trast to most centers in East Asia, ESD has not supplanted
EMR in many European and North American centers,
where it remains the modality of choice for EGC.
Endoscopic ultrasonography and macroscopic assessment
by endoscopy are now widely used not only to diagnose,
but also stage EGCs. Although the diagnostic accuracy rate
of endoscopic assessment and ultrasonography for SM in-
vasion is reported to be around 72.2% [4]. The number of
EGCs with submucosal invasion (SMiGC) unexpectedly di-
agnosed after evaluation of EMR or ESD specimens has
been increasing as a direct consequence of the expansion of
indications for EMR and ESD [5]. This is an important de-
velopment, since SM invasion is the most significant risk
factor for lymph node metastasis and thus for the prognosis
of these patients. Indeed, a large-scale study has reported
that the incidence of lymph node metastasis increases from
2.2% in IMC compared to 17.9% in SMiGCs [6].
To identify pathologic features predicting SM invasion
in pre-treatment biopsies, several studies have reported
results in esophageal and colonic adenocarcinomas;
[7-9] however, no study has been conducted in gastric
mucosal biopsies. The aim of this study was to evaluate
the histologic characteristics of pre-treatment biopsy
specimens to determine whether any histologic feature
can accurately predict SM invasion.
Methods
Study groups
All the cases were selected from EGCs diagnosed on
endoscopic pinch biopsies and treated by EMR between
January 2002 and November 2007 at Samsung Medical
Center, Seoul, Korea. Patients who presented with syn-
chronous GC were excluded.
The first cohort included 60 patients (45 men and 15
women, age range 46–83 years, mean age 65.2 years) who
were diagnosed with SMiGC after EMR. None of these
patients had endosonographic evidence of lymph node or
distant metastases. For the control group, 58 patients(50 men and 8 women, age range 45–84 years, mean age
63.8 years) confirmed to have IMC by EMR during the
same period were included.
The endoscopic gross types of the tumors were classified
using the five-tier classification system of the Japanese
Research Society for Gastric Cancer [10]. The tumor loca-
tion was classified as upper third, middle third, or lower
third of the stomach.
Histologic evaluation of biopsies and endoscopic mucosal
resections
All biopsy specimens were fixed in 10% neutral-buffered
formalin, embedded in paraffin, sectioned at 4 μm thick-
ness, and H&E stained. Three to 13 biopsy fragments
(mean 5.8 fragments) were available for the SMiGC cases
and two to nine fragments (mean 5.1 fragments) for the
IMC control cases. For EMR, specimens were pinned to
cork mats and fixed in 10% neutral-buffered formalin, and
the resection margins were marked by differently colored
inks. The fixed specimens were serially sectioned at 2 mm
intervals and completely embedded. Three pathologists
(Lee SM, Park CK and Kim KM) blinded to the results of
the EMRs reviewed all the pinch biopsies and examined
them for the presence of specific histologic features de-
scribed in previous papers on pathologic findings used to
distinguish high-grade dysplasia from adenocarcinoma in
Barrett’s adenocarcinoma [9,11,12] early colonic carcinoma,
[13-15] and gastric carcinoma [16-21]. These features are
WHO histologic grade (well, moderately and poorly differ-
entiated); poorly differentiated component (single or small
clusters of poorly differentiated carcinoma cells or signet
ring cells in 5% to 50% of the tumor volume) (Figure 1a);
intraluminal amorphous and eosinophilic necrotic cell deb-
ris (IEND) in at least one neoplastic gland (Figure 1b);
wisps of muscularis mucosa entrapped within the neoplas-
tic glands (Figure 1c); papillary architecture (Figure 1d);
tumor cribriforming (Figure 1e); and microscopic ulcers
(Figure 1f). Disagreement in interpretation was resolved by
consensus.
Finally, all EMR specimens were reviewed to confirm
the diagnoses (IMC versus SMiGC), and the depth of
SM invasion was measured as previously described [22].
Briefly, in cases with distorted or lost muscularis mucosa,
immunohistochemical staining with desmin was per-
formed, and the lower aspect of the muscularis mucosa
was projected by drawing an imaginary line reaching both
ends of the discontinuous muscularis mucosa. This line
was used as a baseline, and the distance from this line to
the deepest point of infiltration was measured as the
depth of SM invasion.
Statistical analysis
Statistical analyses were performed using the Statistical
Package for Social Science version 16.0 software for
Figure 1 Representative photomicrographs of pre-treatment biopsies of gastric carcinoma with submucosal invasion. Sheets of poorly
differentiated neoplastic cells within the lamina propria (a); intraluminal amorphous and eosinophilic necrotic cell debris in the lumens of atypical
glands (b); small wisps of smooth muscle fibers entrapped within adenocarcinoma (c); papillary structures with a fibrovascular core (d); tumor
cribriforming (e); and microscopic ulcer with necrotic exudates (f).
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analysis, the χ-square test and Fisher’s exact test were
performed, and for multivariable analysis, each pre-
dictive pathologic factor of SM invasion was analyzed by
multiple logistic regression analyses. Odds ratios and
95% confidence intervals were calculated to estimate the
correlation between SM invasion, clinical factors (age,
sex, and tumor location), and morphologic findings, e.g.,
degree of differentiation, microscopic ulcer, poorly dif-
ferentiated component, wisps of muscularis mucosa,
tumor cribriforming, papillary architecture, desmoplastic
reaction, and IEND.
Independent validation cohort
To validate the significant histologic findings in an ad-
ditional independent cohort, consecutive gastric biopsies
diagnosed as adenocarcinoma from January 1 to October
31, 2010 were reviewed by two other pathologists (Joo M
and Ahn SM). In the 1497 cases, patients with palliative
or multiple cancers, those who were lost to follow-up, or
those confirmed as having advanced carcinomas were ex-
cluded, leaving a final group of 616 gastric cancers.Among these, the depth of invasion was confined to the
mucosa in 423 cases and to the submucosa in 193 cases.
Results
Characteristics of gastric carcinoma with submucosal
invasion in endoscopic resection
A total of 60 SMiGCs were grossly evaluated by routine
endoscopy before EMR. Of these, 34 cases (56.6%) were
located in the lower one-third (antrum). The predo-
minant endoscopic findings were combined type IIa and
IIc in 28 cases (46.7%), followed by type IIa in seven
cases (11.7%) and type IIc in six cases (10%).
Histologic analyses of gastric biopsy specimens
Table 1 summarizes the incidence of the various patho-
logic factors present in the biopsies corresponding to cases
eventually diagnosed as SMiGC or as IMC. Poorly dif-
ferentiated component (p < 0.0001), entrapped wisps of
muscularis mucosa (p = 0.0013), cribriforming (p = 0.0084),
papillary architecture (p = 0.0074), desmoplastic reaction
(p = 0.0157), and IEND (p < 0.0001) were significantly asso-
ciated with SM invasion. However, patient sex, age, tumor
Table 1 Frequency of pathologic factors in biopsies from
patients with intramucosal carcinomas (IMC) and
carcinomas with submucosa invasion (SMiGC)






Well 24 (40) 27 (46.5) 0.4472
Moderate 34 (56.7) 31 (53.5)
Poor 2 (3.3) 0
Microscopic ulcer 26 (43.3) 17 (29.3) 0.1291
Poorly differentiated tumor 22 (36.7) 3 (5.2) <0.0001
Islands of muscularis mucosa 10 (16.7) 0 0.0013
Cribriform pattern 10 (16.7) 1 (1.7) 0.0084
Papillary features 14 (23.3) 3 (5.2) 0.0074
Desmoplastic reaction 24 (40) 11 (19) 0.0157
Intraglandular eosinophilic
necrotic debris
24 (40) 4 (6.9) <0.0001
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statistically associated with SM invasion.
The specificities of poorly differentiated component,
cribriforming, papillary architecture, and IEND for pre-
dicting SMiGC in EMR specimens were 94.8%, 16.7%,
23.3%, and 93.1%, respectively; and their sensitivities
were 36.7%, 16.7%, 23.3%, and 40%, respectively. Com-
binations of any two or three were associated with a
higher specificity but a lower sensitivity (Table 2).
In multivariate analyses after exclusion of histologic grade,
entrapped wisps of muscularis mucosa, and microscopicTable 2 Specificities and sensitivities of “SM invasion-associa
three factors






Combinations of two factors
Poorly differentiated tumor + IEND
Papillary feature + IEND
Cribriform pattern + IEND
Cribriform pattern + papillary feature
Poorly differentiated tumor + papillary feature
Poorly differentiated tumor + cribriform pattern
Combinations of three factors
Cribriform pattern + papillary feature + poorly differentiated tumor
Cribriform pattern + IEND + poorly differentiated tumor
Abbreviations: IEND intraglandular eosinophilic necrotic debris.ulcer, multiple logistic regression analysis corrected by
Bonferroni’s method showed that poorly differentiated
component [odds ratio (OR) 9.59, p = 0.002], IEND [OR
6.23, p = 0.0126], cribriforming [OR 4.66, p = 0.0318], and
papillary architecture [OR 5.52, p = 0.0188] were signifi-
cantly associated with SMiGC.
Evaluation of the significant histologic findings in the
independent validation cohort
In the independent validation cohort, WHO histolo-
gic grade (p < 0.0001), poorly differentiated component
(p < 0.0001) and embedded wisps of muscularis mucosa
(p = 0.0008) were significantly associated with SM inva-
sion. However, cribriforming (p = 0.99), papillary architec-
ture (p = 0.13), desmoplastic reaction (p = 0.09) and IEND
(p = 0.58) were not associated with SM invasion (Table 3).
In multivariate analyses, poorly differentiated component
(p = 0.003) and papillary architecture (p = 0.008) remained
significant (Table 4). The diagnostic sensitivity of poorly
differentiated component was 48.7% (95% CI, 67.9 ~ 55.8)
and specificity was 72.2% (95% CI, 67.9 ~ 76.5). The posi-
tive predictive value of poorly differentiated component
was 43.5% (95% CI, 36.9 ~ 50.1%) and the negative pre-
dictive value was 75.3% (95% CI, 71.1 ~ 79.5).
Discussion
Endoscopic resection has become standard therapy for
selected patients with EGC [23]. Ruling out lymph node
metastasis (and the risk thereof ) is a critical step prior
to attempting EMR or ESD [24]. Lymph node metastasis
is rare in small carcinomas with the intestinal phenotypeted” pathologic factors and combinations of two and
Specificity (95% CI) Sensitivity (95% CI)
94.3% (80.64 - 98.78) 36.7% (22.04 - 54.25)
98.3% (85.71 - 99.82) 16.7% (7.42 - 33.3)
94.8% (80.64 - 98.78) 23.3% (11.9 - 40.67)
93.1% (78.31 - 98.05) 40% (24.76 - 98.78)
100% (88.58 - 100) 15% (6.38 - 31.38)
100% (88.58 - 100) 11.7% (4.42 - 27.31)
100% (88.58 - 100) 8.3% (2.66 - 23.24)
100% (88.58 - 100) 6.7% (1.88 - 21.06)
100% (88.58 - 100) 5% (1.18 - 18.79)
98.3% (85.71 - 99.82)
100% (88.58 - 100) 5% (1.18 - 18.79)
100% (88.58 - 100) 3.3% (0.6 - 11.08)
Table 3 “Submucosa invasion-associated” pathologic factors in 616 validation cohorts
Variables Depth of invasion P value
Submucosa (%) Mucosa (%)
WHO histologic grade <0.0001
Well 114 (59.1) 322 (76.1)
Moderate 34 (17.6) 47 (11.1)
Poor 45 (23.3) 54 (12.8)
Poorly differentiated tumor <0.0001
Absent 99 (51.3) 301 (71.2)
Present 94 (48.7) 122 (28.8)
Islands of muscularis mucosa 0.0008
Absent 160 (82.9) 389 (92.0)
Present 33 (17.1) 34 (8.0)
Cribriform pattern 0.9943
Absent 188 (97.4) 412 (97.4)
Present 5 (2.6) 11 (2.6)
Papillary architecture 0.1327
Absent 132 (68.4) 314 (74.2)
Present 61 (31.6) 109 (25.8)
Intraglandular eosinophilic necrotic debris 0.5814
Absent 128 (66.3) 290 (68.6)
Present 65 (33.7) 133 (31.4)
Desmoplastic reaction 0.0934
Absent 190 (98.4) 422 (99.8)
Present 3 (1.6) 1 (0.2)
Total numbers 193 423
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with SM invasion [25]. Therefore, endoscopic assess-
ment prior to treatment is crucial for deciding whether
the tumor is suitable for EMR [26]. However, the pre-
operative diagnostic accuracy is not high, and the num-
ber of cases with SM invasion detected in the EMR or
ESD specimens is increasing [5].
In an attempt to identify histologic features observed
in pinch biopsies associated with SM invasion in EMR
specimens, we analyzed the cases and found that poorly
differentiated component, IEND, cribriforming, andTable 4 Multiple logistic regression analysis of
“SM invasion-related” pathologic factors
“SM invasion- related”
pathologic factors
Odds ratio (95% CI) p value
Poorly differentiated tumor 2.033 (1.271 ~ 3.25) 0.003
Papillary architecture 1.757 (1.158 ~ 2.666) 0.008
Cribriform pattern 1.254 (0.408 ~ 3.857) 0.693
IEND 1.166 (0.789 ~ 1.724) 0.440
Islands of muscularis mucosa 1.489 (0.838 ~ 2.646) 0.175
Desmoplasia 6.054 (0.569 ~ 64.455) 0.136papillary architecture were significantly associated with
SM invasion in both univariate and multivariate ana-
lyses. However, the degree of differentiation did not
always correlate with SM invasion; this is likely a selec-
tion bias because most cases that are commonly consid-
ered for EMR are the differentiated type. Actually, in the
validation cohort, histologic grade was significantly asso-
ciated with SM invasion. IEND is a distinct pattern of
necrosis composed of amorphous eosinophilic material
admixed with necrotic epithelial fragments within the
lumen of a dilated atypical gland, [27] and it is predomi-
nantly found in moderately differentiated gastric adeno-
carcinomas. In this study, IEND was significantly more
frequent in SMiGCs compared to IMCs. Distinct archi-
tectural patterns, especially papillary architecture and
cribriforming, were also significantly more common in
pre-treatment biopsies of cases with SM invasion than in
those limited to the mucosa. These two architectural
patterns have the same significance in colorectal adeno-
carcinomas [7,20,21].
In our study, poorly differentiated component was the
most significant pathologic factor significantly associated
with SM invasion in the validation cohort. This result is
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ported that poorly differentiated component was closely
associated with SM invasion in the diffuse type of EGCs
and lymph node metastasis [28]. In SMiGCs, poorly dif-
ferentiated component was reported to be significantly as-
sociated with higher risks of lymph node metastasis
[19,29]. Zheng et al. also reported that mixed-type gastric
carcinomas are larger, more deeply invasive into the wall,
and associated with a higher frequency of lymph node
metastasis compared to pure intestinal or diffuse-type car-
cinomas [20].
The present study had several limitations. Pretreat-
ment gastric biopsy may not fully indicate neoplastic
progression in a patient with EGC [30]. An endoscopist
may miss the invasive component of a tumor that har-
bors “SM invasion-associated” histologic features. More-
over, although specificity was high, the sensitivity was
very low. Furthermore, endoscopic biopsy specimens are
small, and thus significant histologic features may be
missed. Despite these limitations, multiple biopsies, ex-
pertise in endoscopy, and higher resolution endoscopy
would be helpful to get higher sensitivity.
In conclusion, poorly differentiated component is the
sole significant histopathologic predictor of SM invasion
in gastric pre-treatment biopsies and should be evalua-
ted and described in pathology reports.
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